亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白
Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
- 編號RPB934Mu03
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞外基質(zhì)
- 預測分子量37.1kDa
- 實際分子量37kDa(差異分析請參閱說明書)
- 片段與標簽Leu37~Leu342 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.1
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome [PubMed: 26351173] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| OncoTargets?and Therapy | leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter [Pubmed:29785123] |
| PROTEOMICS?– Clinical Applications | Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset?… [Pubmed: 30411527] |
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia [Pubmed: 31440093] |
| J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children [Pubmed:35329889] |
留言咨詢
